Research and Markets: Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d426d2/drug_discovery_in) has announced the addition of the "Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting" report to their offering.

“Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting”

Drug Discovery In India and China - Gaining Momentum with Increasing Pressure on Cost Cutting provides key data, information and analysis of the major trends and issues affecting the Drug Discovery market in India and China. The report provides a comprehensive insight into the drug discovery process and the key services that form a part of drug discovery process. The report also provides a detailed analysis of the Indian and Chinese drug market in terms of its size, share in the global drug discovery market, major service offering of the companies in India and China along with the major therapeutic areas of focus under those services. The report also talks about the factors that are driving the drug discovery market in India and China. The report delves into the key regulations, especially with respect to intellectual property rights protection in the two countries and how the regulations have benefited the drug discovery companies in these two nations. It also provides an insight into the government support initiatives in these countries to encourage the drug discovery research. The report also analyses key partnerships between the western pharma and the local companies in the two countries and the key trends emerging out of such partnerships. At the end, the report looks into the major challenges in the future that can restrict the growth of the drug discovery market in India and China.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by a team of industry experts. Rising Financial and Regulatory Pressures on Western Pharma will Continue to Drive the Drug Discovery Research Market Growth in India and China

The pharmaceutical industries in the US and Europe are facing severe financial constraints which are expected to worsen in the years ahead. The pharma companies are under increasing pressure to reduce expenditure due to the increasing cost of introducing a NME (New Molecular Entities) (more than $3 billion in 2008), tightening FDA regulatory issues, blockbuster drugs worth more than $100 billion set to expire by 2014 and drying pipelines. These pressures are expected to drive the companies towards low-cost countries such as India and China to perform their R&D activities, one of their major expenses.

Over the last decade, India and China have developed significant capabilities in drug discovery research along with considerable capabilities in phase I & II clinical trials. Both countries are able to provide significant cost savings in the range of 6070% for discovery research and clinical trials. With discovery research occupying close to one-third of the R&D expenditure for the Western pharmaceutical industry, outsourcing to low-cost countries is logical.

Key Topics Covered:

• 1 TOC
• 2 Introduction
• 3 Drug Discovery Process Overview
• 4 Drug Discovery in India and China Market Characteristics
• 5 IP Protection in India and China Improved IP Protection to Encourage Innovation
• 6 Government and Regulatory Support in India and China Strong Support to Research Institutes and Small Companies
• 7 Major Indian and Chinese Drug Discovery Companies Different Business Models to Provide Similar Services
• 8 Deals Analysis Equal Thrust From Big Pharma and Mid-Size Pharma
• 9 Future Challenges Financial and Intellectual Obstacles to Impede the Future Growth
• 10 Key Takeaway
• 11 Appendix
• List of Tables
• List of Figures
• Companies Mentioned

For more information visit http://www.researchandmarkets.com/research/d426d2/drug_discovery_in